Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 1
2007 1
2008 3
2010 3
2011 6
2012 5
2013 4
2014 6
2015 3
2016 3
2017 9
2018 9
2019 9
2020 2
2021 3
2022 5
2023 5
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma.
Raje N, Berdeja J, Lin Y, Siegel D, Jagannath S, Madduri D, Liedtke M, Rosenblatt J, Maus MV, Turka A, Lam LP, Morgan RA, Friedman K, Massaro M, Wang J, Russotti G, Yang Z, Campbell T, Hege K, Petrocca F, Quigley MT, Munshi N, Kochenderfer JN. Raje N, et al. Among authors: rosenblatt j. N Engl J Med. 2019 May 2;380(18):1726-1737. doi: 10.1056/NEJMoa1817226. N Engl J Med. 2019. PMID: 31042825 Free PMC article. Clinical Trial.
Immunotherapy for the treatment of multiple myeloma.
Boussi LS, Avigan ZM, Rosenblatt J. Boussi LS, et al. Among authors: rosenblatt j. Front Immunol. 2022 Oct 28;13:1027385. doi: 10.3389/fimmu.2022.1027385. eCollection 2022. Front Immunol. 2022. PMID: 36389674 Free PMC article. Review.
Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma.
Sklavenitis-Pistofidis R, Aranha MP, Redd RA, Baginska J, Haradhvala NJ, Hallisey M, Dutta AK, Savell A, Varmeh S, Heilpern-Mallory D, Ujwary S, Zavidij O, Aguet F, Su NK, Lightbody ED, Bustoros M, Tahri S, Mouhieddine TH, Wu T, Flechon L, Anand S, Rosenblatt JM, Zonder J, Vredenburgh JJ, Boruchov A, Bhutani M, Usmani SZ, Matous J, Yee AJ, Jakubowiak A, Laubach J, Manier S, Nadeem O, Richardson P, Badros AZ, Mateos MV, Trippa L, Getz G, Ghobrial IM. Sklavenitis-Pistofidis R, et al. Among authors: rosenblatt jm. Cancer Cell. 2022 Nov 14;40(11):1358-1373.e8. doi: 10.1016/j.ccell.2022.10.017. Cancer Cell. 2022. PMID: 36379208 Free PMC article.
Phase 1 study of CART-ddBCMA for the treatment of subjects with relapsed and refractory multiple myeloma.
Frigault MJ, Bishop MR, Rosenblatt J, O'Donnell EK, Raje N, Cook D, Yee AJ, Logan E, Avigan DE, Jakubowiak A, Shaw K, Daley H, Nikiforow S, Griffin F, Cornwell C, Shen A, Heery C, Maus MV. Frigault MJ, et al. Among authors: rosenblatt j. Blood Adv. 2023 Mar 14;7(5):768-777. doi: 10.1182/bloodadvances.2022007210. Blood Adv. 2023. PMID: 35468618 Free PMC article. Clinical Trial.
Idecabtagene vicleucel for relapsed and refractory multiple myeloma: post hoc 18-month follow-up of a phase 1 trial.
Lin Y, Raje NS, Berdeja JG, Siegel DS, Jagannath S, Madduri D, Liedtke M, Rosenblatt J, Maus MV, Massaro M, Petrocca F, Yeri A, Finney O, Caia A, Yang Z, Martin N, Campbell TB, Rytlewski J, Fuller J, Hege K, Munshi NC, Kochenderfer JN. Lin Y, et al. Among authors: rosenblatt j. Nat Med. 2023 Sep;29(9):2286-2294. doi: 10.1038/s41591-023-02496-0. Epub 2023 Aug 17. Nat Med. 2023. PMID: 37592106 Free PMC article. Clinical Trial.
Vaccine therapy in hematologic malignancies.
Avigan D, Rosenblatt J. Avigan D, et al. Among authors: rosenblatt j. Blood. 2018 Jun 14;131(24):2640-2650. doi: 10.1182/blood-2017-11-785873. Epub 2018 May 4. Blood. 2018. PMID: 29728403 Free article. Review.
Cellular Immunotherapy for Multiple Myeloma.
Rosenblatt J, Avigan D. Rosenblatt J, et al. Cancer J. 2019 Jan/Feb;25(1):38-44. doi: 10.1097/PPO.0000000000000356. Cancer J. 2019. PMID: 30694858 Review.
Personalized tumor vaccine for pancreatic cancer.
Orr S, Huang L, Moser J, Stroopinsky D, Gandarilla O, DeCicco C, Liegel J, Tacettin C, Ephraim A, Cheloni G, Torres D, Kufe D, Rosenblatt J, Hidalgo M, Muthuswamy SK, Avigan D. Orr S, et al. Among authors: rosenblatt j. Cancer Immunol Immunother. 2023 Feb;72(2):301-313. doi: 10.1007/s00262-022-03237-x. Epub 2022 Jul 14. Cancer Immunol Immunother. 2023. PMID: 35834008 Free PMC article.
Vaccination as Immunotherapy in Hematologic Malignancies.
Liegel J, Weinstock M, Rosenblatt J, Avigan D. Liegel J, et al. Among authors: rosenblatt j. J Clin Oncol. 2021 Feb 10;39(5):433-443. doi: 10.1200/JCO.20.01706. Epub 2021 Jan 12. J Clin Oncol. 2021. PMID: 33434056 Review. No abstract available.
Dendritic Cell Therapies for Hematologic Malignancies.
Weinstock M, Rosenblatt J, Avigan D. Weinstock M, et al. Among authors: rosenblatt j. Mol Ther Methods Clin Dev. 2017 Mar 18;5:66-75. doi: 10.1016/j.omtm.2017.03.004. eCollection 2017 Jun 16. Mol Ther Methods Clin Dev. 2017. PMID: 28480306 Free PMC article. Review.
74 results